A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) ...

The programme includes the ECLIPSE 1 and ECLIPSE 2 Phase III trials, aiming to offer registrational data for regulatory ...

If you love the bold taste of black coffee, you're in for a treat! It doesn't just wake you up and start your day, but ...

Local musician and public servant Chris Carillo is fighting for his life, but it’s a battle he can’t win on his own, as his ...

The result suggests that the protein made by the gene, known as Nwd1, and other molecules it interacts with could be ...

As per the Thursday release, Endo will be folded into Mallinckrodt, which will then continue as the holding entity for the ...

Chinese scientists and their Singaporean collaborators have developed a scoring system to predict the risk of recurrence for ...

Strong results to date of Vafseo U.S. launch; expect Vafseo Q1 2025 net product revenues of approximately $10-$11 millionCash resources and cash ...

Normothermic machine perfusion was linked to significant improvements in liver transplant clinical outcomes and reduced hospital resource use, especially among patients who received donation after ...

Obviously, the “she” here is The Pitt and “it all” is the fact that this series is pumping out consistently incredible television that is intense, emotional, and built on this almost impossible ...

Hepatitis B virus (HBV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver-related death globally.1,2 The highest prevalence is found in low-income and middle-income countries ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE registrational program. The ECLIPSE registrational program is designed to evaluate the ...